Press Releases

Page Category: 

BOTHELL, WA - October 14, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that its latest breakthrough in ultrasound imaging, Advanced Needle Visualization, will be featured at the American Society of Anesthesiologists 2010 Annual Meeting. This technology was first introduced in July 2010 and is a proprietary imaging algorithm that intensifies the brightness of the needle, making it clearly visible during a steep angle nerve block approach for deep targets, conditions under which the needle has previously been very difficult to image. The conference is being held in San Diego, California at the San Diego Convention Center, October 16-18, 2010

As a solution for the "lost needle phenomenon," which has been a well-known limitation in ultrasound needle imaging, anesthesiologists worldwide have quickly responded to Advanced Needle Visualization as a key tool for saving time, and improving patient safety. The algorithm enables physicians to increase confidence through visualization of the needle, which may result in less procedure time while maintaining fully-diagnostic image quality from near to far field, preserving anatomical detail.

BOTHELL, WA - October 7, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it will report the company's third quarter financial results on Thursday, October 21, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on that day. The call will be broadcast live and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts .

A replay of the audio webcast will be available beginning October 21, 2010 at 5:30 p.m. PT and can be accessed until November 4, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7304277 is required to access the replay. Additionally, the call will be archived on SonoSite’s website.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA - September 2, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, SonoSite's President and CEO, will present at the Stifel Nicolaus Healthcare Conference being held at the Four Seasons Hotel in Boston from September 15-17, 2010.

The session will be webcast live on Wednesday, September 15 at 11:30 am, Eastern Time. An audio replay will be available for 30 days following and can be accessed via SonoSite's website at www.sonosite.com/investorinformation/webcasts .

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

First Generation Product Provides Unique Tracking and Guidance Technology for PICC Line Procedures

BOTHELL, WA - August 26, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it received FDA clearance for its innovative LumenVu® Catheter Guidance System. Designed to aid in the placement of peripherally inserted central catheters (PICC), the proprietary LumenVu System combines near-infrared technology with a revolutionary fiber optic stylet, which replaces a traditional guide wire, to allow visualization and real-time tracking of a catheter tip as it advances through a vein.

"Receiving FDA clearance is an important milestone in the strategic development and global commercialization of the LumenVu System and it reinforces our dedication to providing patients with improved safety and health," said Kevin M. Goodwin, SonoSite's President and CEO.

"We envision this technology ultimately advancing beyond PICC line placements and potentially into a broader range of clinical applications. This clearance also represents a significant step towards the development of a fully integrated line placement imaging solution, which will include ultrasound visualization."

Mr. Cramer Will Remain on the Board as Chairman Emeritus Through the End of His Term in April 2011 SonoSite's Board Adopts a Smaller and More Simplified Structure for 2011

BOTHELL, WA - August 12, 2010 - SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that Kirby L. Cramer is retiring as non-executive Chairman of the Board of Directors, effective August 12, 2010. As part of the Board's succession plan, Mr. Cramer will continue to serve as a director until SonoSite's 2011 annual meeting of shareholders. SonoSite's Board is naming Robert G. Hauser, M.D., F.A.C.C., F.H.R.S. to serve as non-executive Chairman of the Board. Mr. Cramer and Dr. Hauser will begin working together to create an orderly transition process over the next several weeks.

TRUSTED ADVISOR FOR TWELVE YEARS

UC Irvine Leadership Takes Medical Education to the Next Level by Integrating an Innovative Ultrasound Program and Curriculum BOTHELL, WA - August 11, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the University of California, Irvine, announced today that the company and institution have signed an agreement to integrate ultrasound visualization into UC Irvine's four-year medical school curriculum.

Under the terms of this agreement, SonoSite will act as an exclusive ultrasound partner. The collaborative efforts of both UC Irvine and SonoSite will provide medical students with an active and dynamic learning experience that will transform traditional teaching methods used during medical school training. SonoSite's ultrasound systems will enable students to view anatomical structures in real-time and better understand physiological processes. This innovative ultrasound curriculum is setting the standard for other leading medical institutions and providing UC Irvine's students with the skill set and tools to improve medicine.

BOTHELL, WA - August 10, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside ultrasound for the point-of-care, today announced the retirement of Mike Schuh as Chief Financial Officer. Marcus Smith has been appointed as Senior Vice President and Chief Financial Officer and will replace Mr. Schuh as he retires from his position.

"I'm incredibly fortunate to have worked with such a visionary company and dedicated leadership team over the last ten years," said Mike Schuh. "SonoSite is truly transforming medicine and will continue to make significant contributions to the healthcare industry with its innovative technology and passionate culture that is focused on improving medicine."

"I want to thank Mike for his many contributions and ten years of dedication, hard work, and excellent service," said Kevin M. Goodwin, SonoSite's President and CEO. "Mike has been instrumental in establishing a successful financial infrastructure and serving as a trusted advisor. We wish him the best of luck in retirement."

A key member of SonoSite's executive team, Mr. Smith joined the company in 2007 as Vice President of Corporate Strategy and Growth Planning. He has since led the successful acquisition of SonoSite's primary care business while he served as SonoSite's Vice President and General Manager of Cardiovascular Disease Management.

Revenue Rises 18% EBIT Increases 145%, Excluding Acquisition Charges Gross Margins Rise to 72% Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern BOTHELL, WA - July 26, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the second quarter and first half ended June 30, 2010.

REVENUE Revenue increased 18% in the second quarter to $61.5 million and 13% for the first half of 2010 to $117.5 million, as compared to the prior year comparable periods. These comparisons included revenue of $3.8 million for the quarter and $7.0 million for the first half of 2010 from CardioDynamics (CDIC), which was acquired in the third quarter of 2009. SECOND QUARTER HIGHLIGHTS:

Revenue growth was led by SonoSite's US hospital channel, which was up 20%. Revenue from the international business was impacted by a slowdown in Europe. The Company had steady performances in several other international markets and was up 2%. The International business sector profitability grew 7-8 times the "top line" growth rate, despite the slower revenue. Pricing discipline and an improved product mix led to a 1.4 percentage point increase in gross margins to 72% for the quarter. The Company had strong performances across all four vertical clinical markets.

EBIT and EBITDAS Second Quarter

Major Advancement for Regional Nerve Blocks and Other Injection Based Procedures Highly Advanced Algorithms Were Developed Over Two Years and Aimed at Solving the Disappearing Needle Phenomenon in Anesthesia BOTHELL, WA - July 13, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today introduced Enhanced Needle Visualization, a significant development in ultrasound imaging that enables improved needle tracking with increased confidence during deep needle procedures. Enhanced Needle Visualization is a proprietary imaging technology that intensifies the brightness of the needle, making it clearly visible during a steep angle approach to a deep target, conditions under which the needle has previously been difficult to image. Enhanced Needle Visualization is now available as a software upgrade for SonoSite's M-Turbo® and S Series™ ultrasound product lines.

SonoSite's Enhanced Needle Visualization technology is the first fully-integrated solution to resolve the "lost needle phenomenon,"1which has been an...

BOTHELL, WA - July 8, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it will report the company's second quarter financial results on Monday, July 26, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on that day. The call will be broadcast live and can be accessed via SonoSite's website at www.sonosite.com/investorinformation/webcasts .

A replay of the audio webcast will be available beginning July 26, 2010 at 5:30 p.m. PT and can be accessed until August 9, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 2747293 is required to access the replay. Additionally, the call will be archived on SonoSite's website.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.